Welltory, the consumer health platform that converts wearable data into personalized daily health guidance, has secured a new $2 million credit facility from Braavo Capital to accelerate product growth and international expansion.
The funding will be used to scale user acquisition, expand the company’s global reach, and support the launch of its AI Health Companion, which will provide real-time guidance based on an individual’s physiological signals and daily context. The new financing follows a previous $3 million credit line from Braavo in 2024.
The company has experienced rapid adoption within the preventive health space. Over the past year, Welltory surpassed 16 million installs, entered the Top 10 Health and Fitness apps in the United States, and achieved a 4.8-star rating across major platforms. The company also appeared for the second year in a row on Deloitte’s Technology Fast 500 list.
Welltory focuses on making health insights easier to understand and more actionable. Its platform interprets biometric data from more than 1,000 sources using proprietary HRV and multi-signal analytics, helping users manage stress, sleep, energy levels, and cardiometabolic risks. The app is widely used by adults seeking clear and sustainable guidance for everyday health management, particularly women navigating stress, perimenopause, and chronic lifestyle-related conditions.
The upcoming AI Health Companion will analyze user routines, patterns, and physiology to offer tailored recommendations and will initially launch to paying subscribers before being rolled out to a broader audience. It will also connect users to partner programs, including coaching and insurance navigation services. Recently, Welltory entered a collaboration with Stride to help users more easily access benefits and supplemental support services.
The company plans to continue scaling sustainably by expanding advertising initiatives, supporting new languages, and deepening integrations with wearable and health device ecosystems. Priority development areas include perimenopause support, hypertension, metabolic health monitoring, and chronic stress management.
Braavo Capital noted that Welltory’s approach to product-driven and fiscally disciplined growth aligns closely with its investment strategy. The firm continues to support high-growth mobile app companies in their pursuit of flexible, non-dilutive financing options.
KEY QUOTES
“This funding came at exactly the right time — right before the start of our peak season. It lets us efficiently scale our user base, grow partner-driven revenue alongside subscriptions, and accelerate our AI roadmap while remaining capital-efficient. Braavo has been an ideal long-term partner that’s deeply aligned with how we build.”
“Health is moving from clinics into daily life. People need clear steps they can actually follow — whether that’s managing chronic stress or understanding perimenopause symptoms. That’s where Welltory fits in.”
Jane Smorodnikova, CEO at Welltory
“Welltory exemplifies the kind of business Braavo loves to back — product-led, profitable, and scaling responsibly. We’re proud to continue supporting their mission to make preventive health accessible and engaging for millions worldwide.”
Mark Loranger, CEO at Braavo Capital
